Hamilton Point Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12M | Sell |
33,116
-349
| -1% | -$119K | 1.69% | 19 |
|
|
2026
Q1 | $11.8M | Sell |
33,465
-217
| -0.6% | -$77.4K | 1.81% | 13 |
|
|
2025
Q4 | $11M | Sell |
33,682
-108
| -0.3% | -$34.3K | 1.68% | 13 |
|
|
2025
Q3 | $9.54M | Buy |
33,790
+6
| +0% | +$1.74K | 1.49% | 15 |
|
|
2025
Q2 | $9.43M | Sell |
33,784
-1,226
| -4% | -$347K | 1.55% | 17 |
|
|
2025
Q1 | $10.9M | Sell |
35,010
-204
| -0.6% | -$60.2K | 1.96% | 12 |
|
|
2024
Q4 | $9.18M | Buy |
35,214
+532
| +2% | +$158K | 1.62% | 18 |
|
|
2024
Q3 | $11.2M | Buy |
34,682
+359
| +1% | +$117K | 1.97% | 13 |
|
|
2024
Q2 | $10.7M | Buy |
34,323
+328
| +1% | +$96.4K | 2.04% | 12 |
|
|
2024
Q1 | $9.67M | Sell |
33,995
-1,249
| -4% | -$365K | 1.85% | 15 |
|
|
2023
Q4 | $10.2M | Buy |
35,244
+526
| +2% | +$143K | 2.03% | 13 |
|
|
2023
Q3 | $9.33M | Sell |
34,718
-301
| -0.9% | -$75.1K | 2.3% | 12 |
|
|
2023
Q2 | $7.77M | Sell |
35,019
-394
| -1% | -$91.4K | 1.86% | 19 |
|
|
2023
Q1 | $8.56M | Buy |
35,413
+1,371
| +4% | +$337K | 2.08% | 12 |
|
|
2022
Q4 | $8.94M | Buy |
34,042
+136
| +0.4% | +$36.5K | 2.46% | 11 |
|
|
2022
Q3 | $7.64M | Buy |
33,906
+732
| +2% | +$177K | 2.32% | 12 |
|
|
2022
Q2 | $8.07M | Buy |
33,174
+745
| +2% | +$183K | 2.35% | 11 |
|
|
2022
Q1 | $7.84M | Buy |
32,429
+894
| +3% | +$205K | 2.02% | 16 |
|
|
2021
Q4 | $7.09M | Buy |
31,535
+902
| +3% | +$190K | 1.69% | 26 |
|
|
2021
Q3 | $6.51M | Buy |
30,633
+313
| +1% | +$72K | 1.73% | 26 |
|
|
2021
Q2 | $7.39M | Buy |
30,320
+293
| +1% | +$72.1K | 2% | 19 |
|
|
2021
Q1 | $7.47M | Buy |
30,027
+572
| +2% | +$136K | 2.16% | 17 |
|
|
2020
Q4 | $6.77M | Buy |
29,455
+28
| +0.1% | +$6.46K | 2.13% | 18 |
|
|
2020
Q3 | $7.48M | Buy |
29,427
+864
| +3% | +$214K | 2.64% | 8 |
|
|
2020
Q2 | $6.74M | Buy |
28,563
+549
| +2% | +$125K | 2.6% | 11 |
|
|
2020
Q1 | $5.68M | Buy |
28,014
+1,323
| +5% | +$289K | 2.64% | 8 |
|
|
2019
Q4 | $6.43M | Sell |
26,691
-19
| -0.1% | -$4.19K | 2.45% | 9 |
|
|
2019
Q3 | $5.17M | Buy |
26,710
+631
| +2% | +$121K | 2.11% | 15 |
|
|
2019
Q2 | $4.81M | Buy |
26,079
+247
| +1% | +$44.2K | 2.05% | 17 |
|
|
2019
Q1 | $4.91M | Buy |
25,832
+357
| +1% | +$68.2K | 2.18% | 17 |
|
|
2018
Q4 | $4.96M | Buy |
25,475
+1,319
| +5% | +$257K | 2.52% | 8 |
|
|
2018
Q3 | $5.01M | Buy |
24,156
+74
| +0.3% | +$14.6K | 2.34% | 10 |
|
|
2018
Q2 | $4.45M | Buy |
24,082
+549
| +2% | +$97.1K | 2.2% | 15 |
|
|
2018
Q1 | $4.01M | Buy |
23,533
+28
| +0.1% | +$5.14K | 2.04% | 18 |
|
|
2017
Q4 | $4.09M | Buy |
23,505
+870
| +4% | +$154K | 2.14% | 16 |
|
|
2017
Q3 | $4.22M | Buy |
22,635
+110
| +0.5% | +$19.5K | 2.28% | 14 |
|
|
2017
Q2 | $3.88M | Buy |
22,525
+55
| +0.2% | +$8.95K | 2.18% | 15 |
|
|
2017
Q1 | $3.69M | Buy |
22,470
+410
| +2% | +$68.1K | 2.1% | 15 |
|
|
2016
Q4 | $3.23M | Sell |
22,060
-75
| -0.3% | -$11.3K | 1.99% | 17 |
|
|
2016
Q3 | $3.69M | Buy |
22,135
+7,651
| +53% | +$1.29M | 2.32% | 10 |
|
|
2016
Q2 | $2.2M | Buy |
14,484
+5
| +0% | +$777 | 1.44% | 29 |
|
|
2016
Q1 | $2.17M | Sell |
14,479
-129
| -0.9% | -$19.2K | 1.45% | 31 |
|
|
2015
Q4 | $2.37M | Buy |
14,608
+846
| +6% | +$133K | 1.64% | 26 |
|
|
2015
Q3 | $1.9M | Buy |
13,762
+2,195
| +19% | +$346K | 1.49% | 28 |
|
|
2015
Q2 | $1.78M | Buy |
+11,567
| New | +$1.85M | 1.44% | 32 |
|
Other funds holding AMGN
Hamilton Point Investment Advisors's AMGN Position: Q2 2026 in Review
Hamilton Point Investment Advisors reduced its Amgen (AMGN) stake by 1% in Q2 2026, selling an estimated $119K and leaving 33,116 shares worth $12M. The position accounts for 1.69% of the portfolio, ranked #19.
Hamilton Point Investment Advisors first reported a position in AMGN in Q2 2015 and has held it in 45 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hamilton Point Investment Advisors held 33,116 shares of Amgen worth $12M as of Q2 2026.
- Hamilton Point Investment Advisors sold 349 Amgen shares in Q2 2026, an estimated $119K.
- Amgen made up 1.69% of Hamilton Point Investment Advisors's portfolio in Q2 2026, its #19 holding.
- Hamilton Point Investment Advisors first reported a position in Amgen in Q2 2015 and has held it in 45 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hamilton Point Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.